Revance Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $387k | 44k | 8.79 |
| 2023-09-30 | $505k | 44k | 11.47 |
| 2023-06-30 | $1.1M | 44k | 25.31 |
| 2023-03-31 | $1.4M | 42k | 32.21 |
| 2022-12-31 | $781k | 42k | 18.46 |
| 2022-09-30 | $1.1M | 39k | 26.99 |
| 2022-06-30 | $541k | 39k | 13.83 |
| 2022-03-31 | $763k | 39k | 19.50 |
| 2021-12-31 | $415k | 25k | 16.32 |
| 2021-09-30 | $709k | 25k | 27.86 |
| 2021-06-30 | $754k | 25k | 29.64 |
| 2021-03-31 | $711k | 25k | 27.95 |
| 2020-12-31 | $721k | 25k | 28.35 |
| 2020-09-30 | $639k | 25k | 25.12 |
| 2020-06-30 | $621k | 25k | 24.42 |
| 2020-03-31 | $316k | 21k | 14.80 |
| 2019-12-31 | $346k | 21k | 16.21 |
| 2019-09-30 | $278k | 21k | 13.02 |
| 2019-06-30 | $277k | 21k | 12.97 |
| 2019-03-31 | $245k | 16k | 15.77 |
| 2018-12-31 | $313k | 16k | 20.15 |
| 2018-09-30 | $599k | 24k | 24.86 |
| 2018-06-30 | $426k | 16k | 27.43 |
| 2018-03-31 | $338k | 11k | 30.80 |
| 2017-12-31 | $392k | 11k | 35.72 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors